Genus plc (LON:GNS)
London
· Delayed Price · Currency is GBP · Price in GBX 2,590.00
-60.00 (-2.26%)
At close: Dec 5, 2025
Genus Company Description
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.
The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development.
It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand.
The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Genus plc
| Country | United Kingdom |
| Founded | 1994 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3,190 |
| CEO | Jorgen Kokke |
Contact Details
Address: Matrix House Basingstoke, RG21 4FF United Kingdom | |
| Phone | 44 1256 347 100 |
| Website | genusplc.com |
Stock Details
| Ticker Symbol | GNS |
| Exchange | London Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | GBP |
| ISIN Number | GB0002074580 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jorgen Kokke | Chief Executive Officer and Director |
| Andrew Paul Russell | Chief Financial Officer and Executive Director |
| Dr. Matt Culbertson | Chief Operating Officer |
| Dr. Elena Rice | Head of Research & Development and Chief Scientific Officer |
| Lucie Mary Katja Grant | Group General Counsel and Company Secretary |
| Mark Birri | Chief Corporate Development Officer |
| Angelle R. Rosata SPHR | Chief Human Resources Officer |
| Jim Low | Chief Operating Officer of Genus ABS |
| Janet Duane | Group Financial Controller |